MedTrace Logo

Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations

NCT04780074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-12-14

No results posted yet for this study

Summary

The single-center, randomized, open-label, five-period crossover single-dose bioavailability study with five CoQ10 formulations

Conditions

  • Bioavailability of Coenzyme Q10

Interventions

DIETARY_SUPPLEMENT

Single dose intervention with Standard product (SP)

2 capsules - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP1)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP2)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP3)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP4)

2 capsules - 200 mg total CoQ10

Sponsors & Collaborators

  • Vizera d.o.o.

    collaborator INDUSTRY

  • ADM, Ambulanta družinske medicine, Ljubljana, Slovenia

    collaborator UNKNOWN

  • Adrialab d.o.o., Ljubljana, Slovenia

    collaborator UNKNOWN

  • Tishcon Corp., USA

    collaborator UNKNOWN

  • Institute of Nutrition, Slovenia (Nutris)

    lead OTHER

Principal Investigators

  • Igor Pravst · Nutrition Institute, Ljubljana

  • Tina Modrej Zadnikar · ADM, Ambulanta družinske medicine, Ljubljana, Slovenia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2021-05-21
Completion
2022-12-13

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780074 on ClinicalTrials.gov